Ann: Stable Cell Line for Production of PAT-DX3 Established, page-53

My assumption is no “biggie” will be revealed until PAB has completed tox studies and a phase 1 trial to prove the tech is safe in humans with no severe adverse events.

The big fish want to see it’s at least safe before throwing money at it, even if it means a higher price tag for waiting longer. If it’s not safe the spend wouldve been pointless.

In the short term maybe a small MSA (Master Services Agreement) to collaborate with a company that will give PAB money to fund research into combining their drug with our tech, but those deals arent initially substantial, only covers the costs of operation for those activities.

I wont be waiting for any big reveals until after tox/phase 1’s are done